Search results
Showing 916 to 930 of 2186 results for guidelines
Help us improve NICE: take part in research to help us develop better products and services.
HumiGard for preventing inadvertent perioperative hypothermia (HTG428)
Evidence-based recommendations on HumiGard for preventing inadvertent perioperative hypothermia.
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration (TA155)
Evidence-based recommendations on ranibizumab (Lucentis) and pegaptanib (Macugen) for treating wet age-related macular degeneration in adults.
Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.
NICE has developed a medtech innovation briefing (MIB) on Granulox for managing chronic non-healing wounds .
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment (HTG748)
Early value assessment (EVA) guidance on digital therapy for chronic tic disorders and Tourette syndrome.
Benralizumab for treating severe eosinophilic asthma (TA565)
Evidence-based recommendations on benralizumab (Fasenra) for treating severe eosinophilic asthma in adults.
An approximate guide to the timings for the development of a piece of HealthTech guidance.
Our Medical Technologies Evaluation Programme (MTEP) considers technologies that could offer benefits to patients and the health and social care system over current practice.
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
MMprofiler for prognostic risk classification in multiple myeloma (MIB270)
NICE has developed a medtech innovation briefing (MIB) on MMprofiler for prognostic risk classification in multiple myeloma .
applicable) Why this is important:- The evidence review for the NICE guideline on hearing loss found a lack of evidence to establish the...
NICE has developed a medtech innovation briefing (MIB) on PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection .
Evidence-based recommendations on electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease. This involves delivering electrical impulses to weakened muscles using electrodes placed on the skin.
View recommendations for HTG549Show all sections
Early value assessment (EVA) guidance on the ProKnow cloud-based system for radiotherapy data storage, communication and management.